Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats

Dopamine (DA) replacement therapy with L-DOPA is the standard treatment for Parkinson’s disease (PD). Unfortunately chronic treatment often leads to the development of abnormal involuntary movements (AIMs) referred to as L-DOPA-induced dyskinesia (LID). Accumulating evidence has shown that compensat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Conti, Melissa M., Ostock, Corinne Y., Lindenbach, David, Goldenberg, Adam A., Kampton, Elias, Dell’isola, Rich, Katzman, Aaron C., Bishop, Christopher
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865178/
https://ncbi.nlm.nih.gov/pubmed/24067924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2013.09.017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados